SGLT2 & GLP-1 in Diabetes app for iPhone and iPad

4.6 ( 2336 ratings )

Education Medical
Developer: Med Learning Group

Free

Current version: 1.0.4, last update: 4 years ago
First release : 05 Oct 2019
App size: 185.68 Mb

This tool can be used for peer-to-peer, physician-to-patient, and physician-to-caregiver discussions, allowing you to virtually explore two important drug classes used in type 2 diabetes: SGLT2 inhibitors and GLP-1 receptor agonists. The benefits of these agents are carefully described, matched to a visually engaging depiction of their glucose-lowering mechanisms and their effects on different organ systems.